SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yong-Ki Min, Dong-Yun Lee, Youn-Soo Park, Young-Wan Moon, Seung-Jae Lim, Young-Kyun Lee, DooSeok Choi, Byung-Koo Yoon, A FRAX Experience in Korea: Fracture Risk Probabilities with a Country-specific Versus a Surrogate Model, Journal of Bone Metabolism, 2015, 22, 3, 113

    CrossRef

  2. 2
    R. Theiler, M. Kränzlin, Klinische Interpretation des Knochenfrakturrisikos, Gynäkologische Endokrinologie, 2015, 13, 1, 16

    CrossRef

  3. 3
    Thomas J. Beck, Thomas Fuerst, Kenneth W. Gaither, Santosh Sutradhar, Amy B. Levine, Teresa Hines, Ching-Ray Yu, Robert Williams, Sebastian Mirkin, Arkadi A. Chines, The effects of bazedoxifene on bone structural strength evaluated by hip structure analysis, Bone, 2015, 77, 115

    CrossRef

  4. 4
    Jean-Yves Reginster, Serge Ferrari, Peyman Hadji, Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifene, Current Medical Research and Opinion, 2014, 30, 6, 1165

    CrossRef

  5. 5
    Rasha Khatib, Nancy Santesso, Laura Pickard, Osman Osman, Lora Giangregorio, Carly Skidmore, Alexandra Papaioannou, Fracture risk in long term care: a systematic review and meta-analysis of prospective observational studies, BMC Geriatrics, 2014, 14, 1, 130

    CrossRef

  6. 6
    Simone Tassani, George K. Matsopoulos, The micro-structure of bone trabecular fracture: An inter-site study, Bone, 2014, 60, 78

    CrossRef

  7. 7
    Stuart L. Silverman, Barry S. Komm, Sebastian Mirkin, Use of FRAX®-based fracture risk assessments to identify patients who will benefit from osteoporosis therapy, Maturitas, 2014, 79, 3, 241

    CrossRef

  8. 8
    Xuezhi Jiang, Lauren B. Westermann, Gabriella V. Galleo, John Demko, Kimberly A. Marakovits, Peter F. Schnatz, Age as a Predictor of Osteoporotic Fracture Compared With Current Risk-Prediction Models, Obstetrics & Gynecology, 2013, 122, 5, 1040

    CrossRef

  9. 9
    Patricia A. Downey, Susan B. Perry, Janice M. Anderson, Screening Postmenopausal Women for Fall and Fracture Prevention, Journal of Geriatric Physical Therapy, 2013, 36, 3, 138

    CrossRef

  10. 10
    Simone Tassani, George K. Matsopoulos, Fabio Baruffaldi, 3D identification of trabecular bone fracture zone using an automatic image registration scheme: A validation study, Journal of Biomechanics, 2012, 45, 11, 2035

    CrossRef

  11. 11
    L. Grassi, E. Schileo, F. Taddei, L. Zani, M. Juszczyk, L. Cristofolini, M. Viceconti, Accuracy of finite element predictions in sideways load configurations for the proximal human femur, Journal of Biomechanics, 2012, 45, 2, 394

    CrossRef

  12. 12
    Shuanhu Zhou, Julie Glowacki, Sung Won Kim, Jochen Hahne, Shuo Geng, Stefan M Mueller, Longxiang Shen, Ilan Bleiberg, Meryl S LeBoff, Clinical characteristics influence in vitro action of 1,25-dihydroxyvitamin D3 in human marrow stromal cells, Journal of Bone and Mineral Research, 2012, 27, 9
  13. 13
    Gwang-Young So, Kyung-Ho Park, Dea-Hyun Yoon, Ji-Hoon Ryu, Yong-Soo Choi, Feasibility of FRAX for Prediction of Osteoporotic Vertebral Fractures in Korea, Asian Spine Journal, 2012, 6, 1, 22

    CrossRef

  14. You have free access to this content14
    Lora M Giangregorio, William D Leslie, Lisa M Lix, Helena Johansson, Anders Oden, Eugene McCloskey, John A Kanis, FRAX underestimates fracture risk in patients with diabetes, Journal of Bone and Mineral Research, 2012, 27, 2
  15. 15
    Nicole C. Wright, Jeffrey R. Lisse, Thomas J. Beck, Duane L. Sherrill, M. Jane Mohler, Tamsen Bassford, Jane A. Cauley, Andrea Z. LaCroix, Cora E. Lewis, Zhao Chen, Rheumatoid Arthritis is Associated With Less Optimal Hip Structural Geometry, Journal of Clinical Densitometry, 2012, 15, 1, 39

    CrossRef

  16. 16
    Nelson B Watts, Dima L Diab, A backbone for FRAX?, Journal of Bone and Mineral Research, 2011, 26, 3
  17. 17
    A. M. Sibai, W. Nasser, W. Ammar, M. J. Khalife, H. Harb, G. El-Hajj Fuleihan, Hip fracture incidence in Lebanon: a national registry-based study with reference to standardized rates worldwide, Osteoporosis International, 2011, 22, 9, 2499

    CrossRef

  18. 18
    A. C. Looker, B. Dawson-Hughes, A. N. A. Tosteson, H. Johansson, J. A. Kanis, L. J. Melton, Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance, Osteoporosis International, 2011, 22, 2, 541

    CrossRef

  19. 19
    Maurice Audran, Bernard Cortet, Identification par l’analyse des facteurs cliniques de risque et la densitométrie osseuse des hommes à risque d’ostéoporose, La Presse Médicale, 2011, 40, 11, e489

    CrossRef

  20. 20
    Gillian Tufts, New Treatment Approach for Osteopenia, Journal of Midwifery & Women’s Health, 2011, 56, 1
  21. 21
    Jane A. Cauley, Ghada El-Hajj Fuleihan, Asma Arabi, Saeko Fujiwara, Sergio Ragi-Eis, Andrew Calderon, Siok Bee Chionh, Zhao Chen, Jeffrey R. Curtis, Michelle E. Danielson, David A. Hanley, Heikki Kroger, Annie W.C. Kung, Olga Lesnyak, Jeri Nieves, Wojciech Pluskiewicz, Rola El Rassi, Stuart Silverman, Anne-Marie Schott, Rene Rizzoli, Marjorie Luckey, Official Positions for FRAX® Clinical Regarding International Differences, Journal of Clinical Densitometry, 2011, 14, 3, 240

    CrossRef

  22. 22
    Nelson B. Watts, The Fracture Risk Assessment Tool (FRAX®): Applications in Clinical Practice, Journal of Women's Health, 2011, 20, 4, 525

    CrossRef

  23. 23
    Gillian Tufts, The treatment of osteopenia in Asian women: A new approach, Journal of the American Academy of Nurse Practitioners, 2011, 23, 8
  24. 24
    Nithya Setty, Meryl S. LeBoff, Thomas S. Thornhill, Giulia Rinaldi, Julie Glowacki, Underestimated Fracture Probability in Patients With Unilateral Hip Osteoarthritis as Calculated by FRAX, Journal of Clinical Densitometry, 2011, 14, 4, 447

    CrossRef

  25. 25
    Michelle M. Isley, Andrew M. Kaunitz, Update on hormonal contraception and bone density, Reviews in Endocrine and Metabolic Disorders, 2011, 12, 2, 93

    CrossRef

  26. 26
    Joseph A. Lorenzo, Ernesto Canalis, Lawrence G. Raisz, Williams Textbook of Endocrinology, 2011,

    CrossRef

  27. 27
    Carmen Gómez Vaquero, Daniel Roig Vilaseca, ¿Qué es el FRAX?: pros y contras, Seminarios de la Fundación Española de Reumatología, 2010, 11, 3, 100

    CrossRef

  28. 28
    Nelson Watts, John Bilezikian, Pauline Camacho, Susan Greenspan, Steven Harris, Stephen Hodgson, Michael Kleerekoper, Marjorie Luckey, Michael McClung, Rachel Pollack, Steven Petak, American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis, Endocrine Practice, 2010, 16, Supplement 3, 1

    CrossRef

  29. 29
    Peter F. Schnatz, Kimberly A. Marakovits, David M. OʼSullivan, Assessment of Postmenopausal Women and Significant Risk Factors for Osteoporosis, Obstetrical & Gynecological Survey, 2010, 65, 9, 591

    CrossRef

  30. 30
    Jill Attaman, Beyond identifying women at risk for coronary heart disease and osteoporosis, Menopause, 2010, 17, 2, 233

    CrossRef

  31. 31
    Apurba Mukherjee, Prithwis Mukherjee, Robert R. Rude, Bikram Yoga as a Countermeasure of Bone Loss in Women, Chinese Medicine, 2010, 01, 01, 1

    CrossRef

  32. 32
    Julie Glowacki, Meenu Tuteja, Shelley Hurwitz, Thomas S. Thornhill, Meryl S. LeBoff, Discordance in Femoral Neck Bone Density in Subjects With Unilateral Hip Osteoarthritis, Journal of Clinical Densitometry, 2010, 13, 1, 24

    CrossRef

  33. 33
    Jorge Morales-Torres, Patricia Clark, Margarita Delezé-Hinojosa, Fidencio Cons-Molina, Osvaldo Daniel Messina, Jaime Hernández, Juan José Jaller-Raad, Héctor Quevedo-Solidoro, Sebastiao Cezar Radominski, Fracture risk assessment in Latin America: is Frax™ an adaptable instrument for the region?, Clinical Rheumatology, 2010, 29, 10, 1085

    CrossRef

  34. 34
    Anne Saarinen, Mervi K. Mäyränpää, Anna-Elina Lehesjoki, Outi Mäkitie, Low-density lipoprotein receptor-related protein 5 (LRP5) variation in fracture prone children, Bone, 2010, 46, 4, 940

    CrossRef

  35. 35
    Ethel S. Siris, Sanford Baim, Aurelia Nattiv, Primary Care Use of FRAX®: Absolute Fracture Risk Assessment in Postmenopausal Women and Older Men, Postgraduate Medicine, 2010, 122, 1, 82

    CrossRef

  36. 36
    E. Michael Lewiecki, Risk Communication and Shared Decision Making in the Care of Patients With Osteoporosis, Journal of Clinical Densitometry, 2010, 13, 4, 335

    CrossRef

  37. 37
    Jan L. Shifren, Isaac Schiff, Role of Hormone Therapy in the Management of Menopause, Obstetrics & Gynecology, 2010, 115, 4, 839

    CrossRef

  38. 38
    P. D. Miller, R. J. Derman, What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?, Osteoporosis International, 2010, 21, 11, 1793

    CrossRef

  39. 39
    Eric S. Orwoll, Osteoporosis in Men, 2010,

    CrossRef

  40. 40
    Ronald C Hamdy, FRAX®: a fracture risk-assessment tool, Aging Health, 2009, 5, 4, 489

    CrossRef